iSAM Funds (UK)’s Integra LifeSciences IART Stock Holding History

iSAM Funds (UK)’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,197	Closed	-$96.1K	–	342
2026 Q1	$96.1K	Buy	+10,197	New	+$112K	0.05%	289

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

iSAM Funds (UK)'s IART Position: Q2 2026 in Review

iSAM Funds (UK) sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 10,197 shares — an estimated $96.1K sold.

iSAM Funds (UK) first reported a position in IART in Q1 2026 and held it in 1 quarter. The position peaked at $96.1K in Q1 2026. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

iSAM Funds (UK) reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
iSAM Funds (UK) sold 10,197 Integra LifeSciences shares in Q2 2026, an estimated $96.1K.
iSAM Funds (UK) first reported a position in Integra LifeSciences in Q1 2026 and held it in 1 quarter.
iSAM Funds (UK)'s Integra LifeSciences position peaked at $96.1K in Q1 2026.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on iSAM Funds (UK)'s 13F filing for Q2 2026, filed 12 Aug 2026.